GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nemaura Medical Inc (OTCPK:NMRD) » Definitions » Shiller PE Ratio

Nemaura Medical (Nemaura Medical) Shiller PE Ratio : (As of May. 02, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Nemaura Medical Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Nemaura Medical Shiller PE Ratio Historical Data

The historical data trend for Nemaura Medical's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nemaura Medical Shiller PE Ratio Chart

Nemaura Medical Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Nemaura Medical Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Nemaura Medical's Shiller PE Ratio

For the Medical Devices subindustry, Nemaura Medical's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nemaura Medical's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nemaura Medical's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Nemaura Medical's Shiller PE Ratio falls into.



Nemaura Medical Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Nemaura Medical's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Nemaura Medical's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.07/129.4194*129.4194
=-0.070

Current CPI (Dec. 2023) = 129.4194.

Nemaura Medical Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -0.008 99.695 -0.010
201406 -0.013 100.560 -0.017
201409 -0.018 100.428 -0.023
201412 -0.008 99.070 -0.010
201503 -0.027 99.621 -0.035
201506 -0.020 100.684 -0.026
201509 -0.020 100.392 -0.026
201512 -0.016 99.792 -0.021
201603 -0.020 100.470 -0.026
201606 -0.024 101.688 -0.031
201609 -0.016 101.861 -0.020
201612 -0.018 101.863 -0.023
201703 -0.018 102.862 -0.023
201706 -0.020 103.349 -0.025
201709 -0.019 104.136 -0.024
201712 -0.038 104.011 -0.047
201803 -0.028 105.290 -0.034
201806 -0.100 106.317 -0.122
201809 -0.100 106.507 -0.122
201812 -0.050 105.998 -0.061
201903 -0.090 107.251 -0.109
201906 -0.060 108.070 -0.072
201909 -0.050 108.329 -0.060
201912 -0.020 108.420 -0.024
202003 -0.060 108.902 -0.071
202006 -0.050 108.767 -0.059
202009 -0.070 109.815 -0.082
202012 -0.060 109.897 -0.071
202103 -0.090 111.754 -0.104
202106 -0.140 114.631 -0.158
202109 -0.150 115.734 -0.168
202112 -0.150 117.630 -0.165
202203 -0.150 121.301 -0.160
202206 -0.160 125.017 -0.166
202209 -0.160 125.227 -0.165
202212 -0.070 125.222 -0.072
202303 -0.180 127.348 -0.183
202306 -0.090 128.729 -0.090
202309 -0.050 129.860 -0.050
202312 -0.070 129.419 -0.070

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Nemaura Medical  (OTCPK:NMRD) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Nemaura Medical Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Nemaura Medical's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Nemaura Medical (Nemaura Medical) Business Description

Traded in Other Exchanges
N/A
Address
57 West 57th Street, New York, NY, USA, 10019
Nemaura Medical Inc is a medical technology company developing sugarBEAT as a non-invasive, affordable, and flexible Continuous Glucose Monitor (CGM) designed for people with diabetes and pre-diabetics to manage their glucose levels. Insulin users can adjunctively use sugarBEAT when calibrated with a finger-stick glucose reading. SugarBEAT consists of a daily disposable adhesive skin patch connected to a rechargeable transmitter with an app displaying glucose readings at five-minute intervals for periods up to 24 hours.
Executives
Bashir Timol director, 10 percent owner, officer: Chief Business Officer C/O ONE E GROUP LIMITED, UNIT 3A, SPRINGFIELD COURT, SUMMERFIELD ROAD, BOLTON X0 BL32NT
Chowdhury Dewan Fazlul Hoque director, 10 percent owner, officer: CEO & President CHAMWOOD BUILDING, HOLYWELL PARK, ASHBURY ROAD, LOUGHBOROUGH LEICS X0 LE113AQ
Salim Natha director LOUGHBOROUGHUNIVERSITYSCIENCE&ENTERPRISE, PARKS, 5 OAKWOOD DRIVE, LOUGHBOROUGH, LEICESTERSHIRE X0 LE113QF
Justin James Mclarney officer: Chief Financial Officer C/O NEMAURA MEDICAL INC., 57 WEST 57TH STREET, MANHATTAN NY 10019
Sufyan Ismail 10 percent owner C/O ONE E GROUP LIMITED, UNIT 3A, SPRINGFIELD COURT, SUMMERFIELD ROAD, BOLTON X0 BL32NT
Thomas Peter Moore director C/O NEMAURA MEDICAL, INC., 57 WEST 57TH STREET, MANHATTAN NY 10019
Timothy Christopher Johnson director C/O NEMAURA MEDICAL INC., 57 WEST 57TH STREET, MANHATTAN NY 10019
Iain Anderson officer: CFO LOUGHBOROUGHUNIVERSITYSCIENCE&ENTERPRISE, PARKS, 5 OAKWOOD DRIVE, LOUGHBOROUGH, LEICESTERSHIRE X0 LE113QF
Kathryn Farrar officer: Director of Finance C/O ONE E GROUP LIMITED, UNIT 3A, SPRINGFIELD COURT, SUMMERFIELD ROAD, BOLTON X0 BL32NT
Julie Pomeroy officer: Director of Finance C/O ONE E GROUP LIMITED, UNIT 3A, SPRINGFIELD COURT, SUMMERFIELD ROAD, BOLTON X0 BL32NT
Richard Toon officer: Technical & Bus. Dev. Manager C/O ONE E GROUP LIMITED, UNIT 3A, SPRINGFIELD COURT, SUMMERFIELD ROAD, BOLTON X0 BL32NT